Lisa R.  Diller

Lisa R. Diller, MD

Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Clinical Director, Pediatric Oncology; Medical Director, Clinical Cancer and Blood Disorders Service Line; Medical Director, David B. Perini, Jr. Quality of Life Clinic

Professor of Pediatrics, Harvard Medical School

    Contact: 617-632-5642
  • Fax: 617-582-9049

Medical Services

Specialties

  • Late Effects of Pediatric Cancer
  • Solid Tumors
  • Retinoblastoma
  • Wilms Tumor
  • Cancer Predisposition
  • Melanoma

Departments

  • Hematology / Oncology
  • Medicine

Programs

  • Center for Pediatric Polyposis
  • Neuroblastoma
  • David B. Perini Jr. Quality of Life Clinic
  • Pediatric Cancer Risk Program
To schedule an appointment: Call 617-632-5642

Experience and Education

Education

Medical School

University of California, San Diego School of Medicine, 1985

San Diego, CA

Internship

Boston Children's Hospital, 1986

Boston, MA

Residency

Boston Children's Hospital, 1988

Boston, MA

Fellowship, Pediatric Hematology/Oncology

Boston Children's Hospital/Dana-Farber Cancer Institute, 1991

Boston, MA

Certifications

  • Pediatrics, Pediatric Hematology/Oncology

Professional History

Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for over 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Yeh JM, Hanmer J, Ward ZJ, Leisenring WM, Armstrong GT, Hudson MM, Stovall M, Robison LL, Oeffinger KC, Diller L. Chronic Conditions and Utility-Based Health-Related Quality of Life in Adult Childhood Cancer Survivors. J Natl Cancer Inst. 2016 Sep; 108(9).
  2. Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison LL, Armstrong GT, Diller LR, Oeffinger KC. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2016 Mar 20; 34(9):910-8.
  3. Rosenberg SM, Moskowitz CS, Ford JS, Henderson TO, Frazier AL, Diller LR, Hudson MM, Stanton AL, Chou JF, Smith S, Leisenring WM, Mertens AC, Cox CL, Nathan PC, Krull KR, Robison LL, Oeffinger KC. Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1699-706.
  4. Madenci AL, Fisher S, Diller LR, Goldsby RE, Leisenring WM, Oeffinger KC, Robison LL, Sklar CA, Stovall M, Weathers RE, Armstrong GT, Yasui Y, Weldon CB. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Sep 10; 33(26):2893-900.
  5. Archer NM, Amorim RP, Naves R, Hettmer S, Diller LR, Ribeiro KB, Rodriguez-Galindo C. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome? Pediatr Blood Cancer. 2016 Feb; 63(2):196-201.
  6. Krishnadas DK, Shusterman S, Bai F, Diller L, Sullivan JE, Cheerva AC, George RE, Lucas KG. A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma. Cancer Immunol Immunother. 2015 Oct; 64(10):1251-60.
  7. Park ER, Kirchhoff AC, Perez GK, Leisenring W, Weissman JS, Donelan K, Mertens AC, Reschovsky JD, Armstrong GT, Robison LL, Franklin M, Hyland KA, Diller LR, Recklitis CJ, Kuhlthau KA. Childhood Cancer Survivor Study participants' perceptions and understanding of the Affordable Care Act. J Clin Oncol. 2015 Mar 1; 33(7):764-72.
  8. Masters GA, Krilov L, Bailey HH, Brose MS, Burstein H, Diller LR, Dizon DS, Fine HA, Kalemkerian GP, Moasser M, Neuss MN, O'Day SJ, Odenike O, Ryan CJ, Schilsky RL, Schwartz GK, Venook AP, Wong SL, Patel JD. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2015 Mar 1; 33(7):786-809.
  9. Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan 15; 121(2):286-93.
  10. Perkins JL, Chen Y, Harris A, Diller L, Stovall M, Armstrong GT, Yasui Y, Robison LL, Sklar CA. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014 Aug 15; 120(16):2514-21.
  11. Show all
  12. Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20; 32(21):2217-23.
  13. Kenney LB, Duffey-Lind E, Ebb D, Sklar CA, Grier H, Diller L. Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature. J Pediatr Hematol Oncol. 2014 Apr; 36(3):237-40.
  14. Chen MH, Blackington LH, Zhou J, Chu TF, Gauvreau K, Marcus KJ, Fisher DC, Diller LR, Ng AK. Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation. Leuk Lymphoma. 2014 Nov; 55(11):2477-83.
  15. Saboo SS, Ramaiya N, Jacene H, Rainville I, Diller L, Hornick JL, George S. Synchronous small bowel and atypical primary leiomyosarcoma of inferior vena cava in a patient with RB1 mutation. Abdom Imaging. 2014 Feb; 39(1):33-9.
  16. Cohen LE, Gordon JH, Popovsky EY, Gunawardene S, Duffey-Lind E, Lehmann LE, Diller LR. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems. Bone Marrow Transplant. 2014 Apr; 49(4):502-8.
  17. Emmons KM, Puleo E, Sprunck-Harrild K, Ford J, Ostroff JS, Hodgson D, Greenberg M, Diller L, de Moor J, Tyc V. Partnership for health-2, a web-based versus print smoking cessation intervention for childhood and young adult cancer survivors: randomized comparative effectiveness study. J Med Internet Res. 2013 Nov 05; 15(11):e218.
  18. Huang TT, Chen Y, Dietz AC, Yasui Y, Donaldson SS, Stokes DC, Stovall M, Leisenring WM, Sklar CA, Diller LR, Mertens AC, Armstrong GT, Green DM, Robison LL, Ness KK. Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014 Feb; 61(2):319-25.
  19. Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014 Jan; 61(1):53-67.
  20. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013 Aug; 14(9):873-81.
  21. Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013 Jun 20; 31(18):2282-8.
  22. Seif AE, Naranjo A, Baker DL, Bunin NJ, Kletzel M, Kretschmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, Park JR, Diller LR, Grupp SA. A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1. Bone Marrow Transplant. 2013 Jul; 48(7):947-52.
  23. Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, Diller L, Schmidt ML, Maris JM, Cohn SL, Shamberger RC. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. Ann Surg. 2012 Oct; 256(4):573-80.
  24. Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, Ng AK. Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. Ann Oncol. 2013 Jan; 24(1):226-30.
  25. Yeh JM, Diller L. Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks. Blood. 2012 Sep 13; 120(11):2195-202.
  26. Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, Mertens A, Meadows A, Neglia JP, Hammond S, Whitton J, Inskip PD, Robison LL, Diller L. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys. 2012 Sep 1; 84(1):224-30.
  27. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012 Jun 5; 156(11):757-66, W-260.
  28. Henderson TO, Oeffinger KC, Whitton J, Leisenring W, Neglia J, Meadows A, Crotty C, Rubin DT, Diller L, Inskip P, Smith SA, Stovall M, Constine LS, Hammond S, Armstrong GT, Robison LL, Nathan PC. Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. Ann Intern Med. 2012 Jun 5; 156(11):I-36.
  29. Park ER, Kirchhoff AC, Zallen JP, Weissman JS, Pajolek H, Mertens AC, Armstrong GT, Robison LL, Donelan K, Recklitis CJ, Diller LR, Kuhlthau KA. Childhood Cancer Survivor Study participants' perceptions and knowledge of health insurance coverage: implications for the Affordable Care Act. J Cancer Surviv. 2012 Sep; 6(3):251-9.
  30. Chen AB, Feng Y, Neuberg D, Recklitis C, Diller LR, Mauch PN, Ng AK. Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study. Leuk Lymphoma. 2012 Aug; 53(8):1474-80.
  31. George RE, Perez-Atayde AR, Yao X, London WB, Shamberger RC, Neuberg D, Diller L. Tumor histology during induction therapy in patients with high-risk neuroblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):506-10.
  32. Diller L. Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia. N Engl J Med. 2011 Oct 13; 365(15):1417-24.
  33. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, Baker KS, Francisco L, Teh JB, Mills G, Wong FL, Rosenthal J, Diller LR, Hudson MM, Oeffinger KC, Forman SJ, Robison LL, Bhatia S. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011 Aug 4; 118(5):1413-20.
  34. de Moor JS, Puleo E, Ford JS, Greenberg M, Hodgson DC, Tyc VL, Ostroff J, Diller LR, Levy AG, Sprunck-Harrild K, Emmons KM. Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. BMC Cancer. 2011 May 11; 11:165.
  35. Goldsby R, Chen Y, Raber S, Li L, Diefenbach K, Shnorhavorian M, Kadan-Lottick N, Kastrinos F, Yasui Y, Stovall M, Oeffinger K, Sklar C, Armstrong GT, Robison LL, Diller L. Survivors of childhood cancer have increased risk of gastrointestinal complications later in life. Gastroenterology. 2011 May; 140(5):1464-71.e1.
  36. Chen MH, Colan SD, Diller L. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res. 2011 Mar 4; 108(5):619-28.
  37. Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL. The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2011 Dec 1; 57(6):1062-6.
  38. Kris MG, Benowitz SI, Adams S, Diller L, Ganz P, Kahlenberg MS, Le QT, Markman M, Masters GA, Newman L, Obel JC, Seidman AD, Smith SM, Vogelzang N, Petrelli NJ. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2010 Dec 20; 28(36):5327-47.
  39. McCullough L, Ng A, Najita J, Janov A, Henderson T, Mauch P, Diller L. Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer. 2010 Oct 15; 116(20):4866-71.
  40. George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, Blaney SM, Diller L. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct; 55(4):629-38.
  41. Frazier AL, Shamberger RC, Henderson TO, Diller L. Decision analysis to compare treatment strategies for Stage I/favorable histology Wilms tumor. Pediatr Blood Cancer. 2010 Jul 1; 54(7):879-84.
  42. George RE, Diller L, Bernstein ML. Pharmacotherapy of neuroblastoma. Expert Opin Pharmacother. 2010 Jun; 11(9):1467-78.
  43. Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010 Apr 6; 152(7):409-17, W131-8.
  44. Kenney LB, Nancarrow CM, Najita J, Vrooman LM, Rothwell M, Recklitis C, Li FP, Diller L. Health status of the oldest adult survivors of cancer during childhood. Cancer. 2010 Jan 15; 116(2):497-505.
  45. Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. J Clin Oncol. 2010 Feb 10; 28(5):878-83.
  46. Laufer MR, Upton J, Schuster SR, Grier H, Emans SJ, Diller L. Ovarian tissue autologous transplantation to the upper extremity for girls receiving abdominal/pelvic radiation: 20-year follow-up of reproductive endocrine function. J Pediatr Adolesc Gynecol. 2010 Apr; 23(2):107-10.
  47. Park ER, Bober SL, Campbell EG, Recklitis CJ, Kutner JS, Diller L. General internist communication about sexual function with cancer survivors. J Gen Intern Med. 2009 Nov; 24 Suppl 2:S407-11.
  48. Recklitis CJ, Diller LR, Li X, Najita J, Robison LL, Zeltzer L. Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010 Feb 1; 28(4):655-61.
  49. Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, Diller L. Caring for cancer survivors: a survey of primary care physicians. Cancer. 2009 Sep 15; 115(18 Suppl):4409-18.
  50. Laverdière C, Liu Q, Yasui Y, Nathan PC, Gurney JG, Stovall M, Diller LR, Cheung NK, Wolden S, Robison LL, Sklar CA. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009 Aug 19; 101(16):1131-40.
  51. Inskip PD, Robison LL, Stovall M, Smith SA, Hammond S, Mertens AC, Whitton JA, Diller L, Kenney L, Donaldson SS, Meadows AT, Neglia JP. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009 Aug 20; 27(24):3901-7.
  52. Shulman LN, Jacobs LA, Greenfield S, Jones B, McCabe MS, Syrjala K, Diller L, Shapiro CL, Marcus AC, Campbell M, Santacroce S, Kagawa-Singer M, Ganz PA. Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009 May; 5(3):119-23.
  53. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, Leisenring WM, Meacham LR, Mertens AC, Mulrooney DA, Oeffinger KC, Packer RJ, Robison LL, Sklar CA. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009 May 10; 27(14):2339-55.
  54. Shapiro CL, McCabe MS, Syrjala KL, Friedman D, Jacobs LA, Ganz PA, Diller L, Campell M, Orcena K, Marcus AC. The LIVESTRONG Survivorship Center of Excellence Network. J Cancer Surviv. 2009 Mar; 3(1):4-11.
  55. Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter L, Sweetenham J, Vahdat L, Schilsky RL. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol. 2009 Feb 10; 27(5):812-26.
  56. Emmons KM, Puleo E, Mertens A, Gritz ER, Diller L, Li FP. Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study. J Clin Oncol. 2009 Jan 1; 27(1):52-60.
  57. Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF, Syngal S, Garber JE. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008 Mar 19; 299(11):1315-9.
  58. Radulescu VC, Gerrard M, Moertel C, Grundy PE, Mathias L, Feusner J, Diller L, Dome JS. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis. Pediatr Blood Cancer. 2008 Feb; 50(2):246-9.
  59. Ng AK, Li S, Recklitis C, Diller LR, Neuberg D, Silver B, Mauch PM. Health practice in long-term survivors of Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2008 Jun 1; 71(2):468-76.
  60. Kuohung W, Ram K, Cheng DM, Marcus KJ, Diller LR, Laufer MR. Laparoscopic oophoropexy prior to radiation for pediatric brain tumor and subsequent ovarian function. Hum Reprod. 2008 Jan; 23(1):117-21.
  61. Recklitis CJ, Licht I, Ford J, Oeffinger K, Diller L. Screening adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. Psychooncology. 2007 Nov; 16(11):1046-9.
  62. O'Leary TE, Diller L, Recklitis CJ. The effects of response bias on self-reported quality of life among childhood cancer survivors. Qual Life Res. 2007 Sep; 16(7):1211-20.
  63. George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One. 2007 Feb 28; 2(2):e255.
  64. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007 Feb 21; 99(4):300-8.
  65. Bober SL, Park ER, Schmookler T, Medeiros Nancarrow C, Diller L. Perceptions of breast cancer risk and cancer screening: a qualitative study of young, female Hodgkin's disease survivors. J Cancer Educ. 2007; 22(1):42-6.
  66. Duffey-Lind EC, O'Holleran E, Healey M, Vettese M, Diller L, Park ER. Transitioning to survivorship: a pilot study. J Pediatr Oncol Nurs. 2006 Nov-Dec; 23(6):335-43.
  67. Guinan EC, Kalish LA, Berry WS, McDaniel S, Lehmann LE, Diller LR. A novel pattern of transaminase elevation associated with autologous transplant for neuroblastoma. Pediatr Transplant. 2006 Sep; 10(6):669-76.
  68. Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR. Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol. 2006 Aug 20; 24(24):3852-7.
  69. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol. 2006 Jun 20; 24(18):2891-6.
  70. Ng AK, Li S, Recklitis C, Neuberg D, Chakrabarti S, Silver B, Diller L. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol. 2005 Dec; 16(12):1949-55.
  71. George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 2005 Sep 20; 23(27):6466-73.
  72. Seefelder C, Sparks JW, Chirnomas D, Diller L, Shamberger RC. Perioperative management of a child with severe hypertension from a catecholamine secreting neuroblastoma. Paediatr Anaesth. 2005 Jul; 15(7):606-10.
  73. Carpentieri SC, Diller LR. Neuropsychological resiliency after treatment for advanced stage neuroblastoma. Bone Marrow Transplant. 2005 Jun; 35(11):1117-22.
  74. von Allmen D, Grupp S, Diller L, Marcus K, Ecklund K, Meyer J, Shamberger RC. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg. 2005 Jun; 40(6):936-41; discussion 941.
  75. Kumanyika SK, Cook NR, Cutler JA, Belden L, Brewer A, Cohen JD, Hebert PR, Lasser VI, Raines J, Raczynski J, Shepek L, Diller L, Whelton PK, Yamamoto M. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens. 2005 Jan; 19(1):33-45.
  76. Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, Mertens AC, Meadows AT, Friedman D, Robison LL, Diller L. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004 Oct 19; 141(8):590-7.
  77. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004 Aug 1; 22(15):3139-48.
  78. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipschultz SE. . Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. Journal of Clinical Oncology. 2004; 22(15):3139-3148.
  79. George RE, Lipshultz SE, Lipsitz SR, Colan SD, Diller L. Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr. 2004 Apr; 144(4):444-8.
  80. Diller L, Mauch P, Medeiros-Nancarrow C, Byrnes L, Stevenson MA, Ng A, Garber J. . A feasibility study of tamoxifen chemotherapy prevention in Hodgkin’s disease (HD) survivors. Long-Term Complications of Treatment of Children and Adolescents for Cancer. 2004; (Ontario).
  81. Duffey-Lind EC, O’Holleran E, Healey M, Vettese M, Diller L. . Transitioning to survivorship: a pilot study. Long-Term Complications of Treatment of Children and Adolescents for Cancer. 2004; (Ontario).
  82. Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms. J Clin Oncol. 2003 Dec 15; 21(24):4505-9.
  83. Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L. . The TP53, BRCA1 and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin’s disease with second primary neoplasms. Journal of Clinical Oncology. 2003; 21(24):4505-9.
  84. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol. 2003 Dec 1; 158(11):1108-13.
  85. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003 Dec 1; 21(23):4386-94.
  86. Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Nancarrow CM, Goldwein J, Grier HE, Diller L. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol. 2003 Dec; 25(12):934-40.
  87. Recklitis C, O'Leary T, Diller L. Utility of routine psychological screening in the childhood cancer survivor clinic. J Clin Oncol. 2003 Mar 1; 21(5):787-92.
  88. Recklitis C, O'Leary T, Diller L. . Utility of routine psychological screening in the childhood cancer survivor clinic. Journal of Clinical Oncology. 2003; 21(5):787-92.
  89. Grupp SA, Ash S, Donovan J, Temel J, Zuckerman A, Fang J, Pierson G, Ross A, Diller L, Gribben J. . Successful purging of stem cell products using CD34 selection. Transplantation in Hematology and Oncology II, Berdel WE, et al, eds. 2003; 116-129.
  90. Grupp SA, Stern JW, Bunin N, von Allmen D, Pierson G, Nancarrow C, Adams R, Griffin G, Diller L. . Rapid Sequence Tandem Transplant in Children with High-Risk Neruroblastoma. Transplantation in Hematology and Oncology II, Berdel WE, et al, eds. 2003; 270-279.
  91. Fang J, Stern JW, Shusterman S, Alcorn K, Pierson G, Barr R, Pawel B, Diller L, Maris JM, Grupp SA. . Angiogenesis inhibitor TNP-470 during bone marrow transplant and in minimal residual disease. Transplantation in Hematology and Oncology II, Berdel WE, et al, eds. 2003; 283-298.
  92. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Belani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT. . High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin disease: report from the Late Effects Study Group (LESG). Journal of Clinical Oncology. 2003; 21(23):4386-94.
  93. Ehrlich M, Hopkins NE, Jiang G, Dome JS, Yu MC, Woods CB, Tomlinson GE, Chintagumpala M, Champagne M, Diller L, Parham DM, Sawyer J. . Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genetics and Cytogenetics. 2003; 141(2):97-105.
  94. Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Medeiros-Nancarrow C, Goldwin J, Grier HE, Diller L. . Primary tumor control in patients with stage 3 and 4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. Journal of Pediatric Hematology/Oncology. 2003; 25(12):934-40.
  95. Diller L, Medeiros Nancarrow C, Shaffer K, Matulonis U, Mauch P, Neuberg D, Tarbell NJ, Litman H, Garber J. Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol. 2002 Apr 15; 20(8):2085-91.
  96. Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, Robison LL. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002 Mar 15; 20(6):1608-16.
  97. 26. Diller L, Medeiros-Nancarrow C, Shaffer K, Matulonis U, Mauch P, Neuberg D, Tarbell N, Litman H and Garber J. . Breast cancer screening in women previously treated for Hodgkin’s disease: A prospective cohort study. Journal of Clinical Oncology. 2002; 20(8):2085-2091.
  98. Carpentieri SC, Diller L. . Neuropsychological and psychosocial resiliency in children treated for neuroblastoma. Advances in Neuroblastoma Research. 2002; (Paris).
  99. George R, London WB, Maris JM, Cohn SL, Diller L. . MYCN copy number and hyperdiploidy: do they define a favourable prognostic group in neuroblastoma patients between 12 and 24 months of age? A COG study. Advances in Neuroblastoma Research. 2002; (Paris ).
  100. Grupp SA, Bowman LC, von Allmen D, Guzikowski V, Aplenc R, Shamberger R, Marcus KC, Diller L. . Rapid sequence tandem transplant for advanced neuroblastoma: update and patterns of relapse. Advances in Neuroblastoma Research. 2002; (Paris).
  101. Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, and Robison LL. . Predictors of Smoking Initiation and Cessation Among Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 2002; 20(6):1608-1616.
  102. Cohen JG, Dryja TP, Davis KB, Diller LR, Li FP. RB1 genetic testing as a clinical service: a follow-up study. Med Pediatr Oncol. 2001 Oct; 37(4):372-8.
  103. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene. 2001 Jul 27; 20(33):4441-9.
  104. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001 Feb 1; 91(3):613-21.
  105. Stern JW, Fang J, Shusterman S, Pierson G, Barr R, Pawel B, Diller L and Grupp SA. . Angiogenesis inhibitor TNP-470 during bone marrow transplant: Safety in a preclinical model. Clinical Cancer Research. 2001; 7:1026-32.
  106. Donovan J, Temel J, Zuckerman A, Gribben J, Fang J, Pierson G, Ross A, Diller L, Grupp SA. CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies. Med Pediatr Oncol. 2000 Dec; 35(6):677-82.
  107. Grupp SA, Stern JW, Bunin N, Nancarrow C, Adams R, Gorlin JB, Griffin G, Diller L. Rapid-sequence tandem transplant for children with high-risk neuroblastoma. Med Pediatr Oncol. 2000 Dec; 35(6):696-700.
  108. Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M, Adams R, Grier HE, Gorlin JB, Shamberger R, Marcus K, Neuberg D, Weinstein HJ, Diller L. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol. 2000 Jul; 18(13):2567-75.
  109. Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2000 May; 18(10):2026-31.
  110. Rath JF, Simon D, Langenbahn DM, Sherr RL, Diller L. Measurement of problem-solving deficits in adults with acquired brain damage. J Head Trauma Rehabil. 2000 Feb; 15(1):724-33.
  111. Diller L. ADHD, divorce, and parental disagreement about the diagnosis and treatment. J Dev Behav Pediatr. 2000 Feb; 21(1):53-5.
  112. Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller, L. . Characteristics and outcome of children with Beckwith-Weidemann syndrome and Wilms tumor: a report from the National Wilms Tumor Study Group. Journal of Clinical Oncology. 2000; 18:2026-31.
  113. Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M, Adams R, Grier HE, Gorlin JB, Shamberger R, Marcus K, Neuberg D, Weinstein HJ, Diller L. . Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. Journal of Clinical Oncology. 2000; 18(13):2567-75.
  114. Dacey D, Packer OS, Diller L, Brainard D, Peterson B, Lee B. Center surround receptive field structure of cone bipolar cells in primate retina. Vision Res. 2000; 40(14):1801-11.
  115. Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J Clin Oncol. 1999 Apr; 17(4):1259.
  116. Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L. . Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin’s disease. Journal of Clinical Oncology. 1999; 4:1259-66.
  117. Diller L, Ghahremani M, Morgan J, Grundy P, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP. Constitutional WT1 mutations in Wilms' tumor patients. J Clin Oncol. 1998 Nov; 16(11):3634-40.
  118. Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant. 1998 Oct; 22(7):669-74.
  119. Nichols KE, Li FP, Haber DA, Diller L. Childhood cancer predisposition: applications of molecular testing and future implications. J Pediatr. 1998 Mar; 132(3 Pt 1):389-97.
  120. Kozakewich HP, Perez-Atayde AR, Donovan MJ, Fletcher JA, Estroff JA, Shamberger RC, Diller L. Cystic neuroblastoma: emphasis on gene expression, morphology, and pathogenesis. Pediatr Dev Pathol. 1998 Jan-Feb; 1(1):17-28.
  121. Diller L, Ghahremani M, Morgan J, Grundy P, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP. . Constitutional WT1 mutations in Wilms tumor patients. Journal of Clinical Oncology. 1998; 11:3634-40.
  122. Kozakewich H, Perez-Atayde AR, Donovan MJ, Fletcher JA, Estroff JA, Shamberger RC, Diller L. . Cystic neuroblastoma: emphasis on gene expression, morphology, and pathogenesis. Pediatric and Developmental Pathology. 1998; 1:17-28.
  123. Diller L, Morrow R. The case of the missing methylphenidate. Pediatrics. 1997 Oct; 100(4):730-1.
  124. Laufer MR, Townsend NL, Parsons KE, Brody KA, Diller LR, Emans SJ, Guinan EC. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. J Reprod Med. 1997 Sep; 42(9):537-41.
  125. Diller L Li FP. . Epidemiology of cancer in childhood.Eds. Nathan DG, Orkin SH. In: Nathan and Oski’s Hematology of Infancy and Childhood. 1997; 1071-91.
  126. Diller L. Use of growth hormone for non-growth hormone deficient children. JAMA. 1996 Dec 18; 276(23):1877-8; author reply 1878.
  127. Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR, Pelletier J. Germline WT1 mutations in Wilms' tumor patients: preliminary results. Med Pediatr Oncol. 1996 Nov; 27(5):404-7.
  128. Hoffer FA, Chung T, Diller L, Kozakewich H, Fletcher JA, Shamberger RC. Percutaneous biopsy for prognostic testing of neuroblastoma. Radiology. 1996 Jul; 200(1):213-6.
  129. Chan CY, Molrine DC, George S, Tarbell NJ, Mauch P, Diller L, Shamberger RC, Phillips NR, Goorin A, Ambrosino DM. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis. 1996 Jan; 173(1):256-8.
  130. Gorlin JB, Humphreys D, Kent P, Galacki D, Kevy SV, Grupp S, Diller L, Weinstein H, Grier H, Shamberger R. Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: a primer. J Clin Apher. 1996; 11(4):195-203.
  131. Chan CY, Molrine DC, George S, Tarbell NJ, Mauch P, Diller L, Shamberger RC, Phillips NR, Goorin A, Ambrosino DM. ; ():. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin’s disease. Journal of Infectious Diseases. 1996; 173(1):256-8.
  132. Molrine DC, George S, Tarbell N, Mauch P, Diller L, Neuberg D, Shamberger RC, Anderson EL, Phillips NR, Kinsella K, Ambrosino DM. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease. Ann Intern Med. 1995 Dec 1; 123(11):828-34.
  133. Diller L, Sexsmith E, Gottlieb A, Li FP, Malkin D. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest. 1995 Apr; 95(4):1606-11.
  134. Laufer MR, Billett AL, Diller L, Chin LM, Tarbell NJ. . A new technique for laparoscopic prophylactic oophoropexy prior to cranial irradiation in children with medulloblastoma. Adolescent and Pediatric Gynecology. 1995; 8:77-81.
  135. Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Prog Clin Biol Res. 1994; 385:43-9.
  136. Schneider KA, Diller L, Garber JE. . Overview of Familial Cancers. Genetic Resource. 1994; 8:12-19.
  137. Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NV, Cohn SL, Diller L, Sapienza C, Brodeur GM. Eds. Evans AE, Bidler JL, Brodeur GM, D’Angio GJ, Nakagawara A. . Preferential amplification of the paternal allele in neuroblastomas with n-myc amplification. In: Advances in Neuroblastoma Research. 1994; 39-43.
  138. Garber JE, Diller L. Screening children at genetic risk of cancer. Curr Opin Pediatr. 1993 Dec; 5(6):712-5.
  139. Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nat Genet. 1993 Jun; 4(2):191-4.
  140. Ben-Yishay Y, Diller L. Cognitive remediation in traumatic brain injury: update and issues. Arch Phys Med Rehabil. 1993 Feb; 74(2):204-13.
  141. Miller AC, Gordon RM, Daniele RJ, Diller L. Stress, appraisal, and coping in mothers of disabled and nondisabled children. J Pediatr Psychol. 1992 Oct; 17(5):587-605.
  142. Destrée OH, Lam KT, Peterson-Maduro LJ, Eizema K, Diller L, Gryka MA, Frebourg T, Shibuya E, Friend SH. Structure and expression of the Xenopus retinoblastoma gene. Dev Biol. 1992 Sep; 153(1):141-9.
  143. Diller L. Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol. 1992 Aug; 4(4):689-95.
  144. Diller L, Friend SH. Identification of cancer-prone individuals: p53 and family cancer syndromes. J Natl Cancer Inst Monogr. 1992; (12):123-4.
  145. Cancer Survivor Initiative Project (National Cancer Institute Contract MAO NCICC)-84332 (PI:Patenaude). Curriculum for health care providers working with young adult survivors. Co-author of medical information summaries section of curriculum. 1992.
  146. Estroff JA, Shamberger RC, Diller L, Benacerraf BR. . Neuroblastoma. The Fetus. 1991; 1:1-4.
  147. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 1990 Nov; 10(11):5772-81.
  148. Borod JC, Welkowitz J, Alpert M, Brozgold AZ, Martin C, Peselow E, Diller L. Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord. 1990 Aug-Oct; 23(4-5):247-71.
  149. Egelko S, Simon D, Riley E, Gordon W, Ruckdeschel-Hibbard M, Diller L. First year after stroke: tracking cognitive and affective deficits. Arch Phys Med Rehabil. 1989 Apr; 70(4):297-302.
  150. Egelko S, Riley E, Simon D, Diller L, Ezrachi O. Unilateral spatial neglect: biases in contralateral search and fine spatial attention. Arch Clin Neuropsychol. 1988; 3(3):213-25.
  151. Grossman M, Carey S, Zurif E, Diller L. Proper and common nouns: form class judgments in Broca's aphasia. Brain Lang. 1986 May; 28(1):114-25.
  152. Freidenbergs I, Gordon W, Hibbard M, Levine L, Wolf C, Diller L. Psychosocial aspects of living with cancer: a review of the literature. Int J Psychiatry Med. 1981-1982; 11(4):303-29.
  153. Diller L, Hembree W. Male contraception and family planning: a social and historical review. Fertil Steril. 1977 Dec; 28(12):1271-9.
  154. Sarno MT, Sarno JE, Diller L. The effect of hyperbaric oxygen on communication function in adults with aphasia secondary to stroke. J Speech Hear Res. 1972 Mar; 15(1):42-8.
  155. Berel M, Diller L, Orgel M. Music as a facilitator for visual motor sequencing tasks in children with cerebral palsy. Dev Med Child Neurol. 1971 Jun; 13(3):335-42.
  156. Diller L. Perceptual and intellectual problems in hemiplegia: implications for rehabilitation. Med Clin North Am. 1969 May; 53(3):575-83.
  157. Ben-Yishay Y, Diller L, Gerstman L, Haas A. The relationship between impersistence, intellectual function and outcome of rehabilitation in patients with left hemiplegia. Neurology. 1968 Sep; 18(9):852-61.
  158. DILLER L, RIKLAN M, WOOD J. Follow-up study of the results of anterior choroidal artery occlusion and subtemporal chemopallidectomy in parkinson's disease: an independent appraisal. J Am Geriatr Soc. 1956 Dec; 4(12):1249-57.
  159. Stern JW, Fang J, Shusterman S, Pierson G, Barr R, Pawel B, Diller L, Grupp SA. Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model. Clin Cancer Res. 2001 Apr; 7(4):1026-32.
  160. London WB, Frantz CN, Campbell LA, Seeger RC, Brumback BA, Cohn SL, Matthay KK, Castleberry RP, Diller L. Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2010 Aug 20; 28(24):3808-15.
  161. Smith SM, Ford JS, Rakowski W, Moskowitz CS, Diller L, Hudson MM, Mertens AC, Stanton AL, Henderson TO, Leisenring WM, Robison LL, Oeffinger KC. Inconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study. Cancer Causes Control. 2010 Oct; 21(10):1585-95.
  162. Ho PT, Estroff JA, Kozakewich H, Shamberger RC, Lillehei CW, Grier HE, Diller L. Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children's Hospital. Pediatrics. 1993 Sep; 92(3):358-64.
  163. Yu JH, Nakajima A, Nakajima H, Diller LR, Bloch KD, Bloch DB. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness. Cancer Res. 2004 Feb 1; 64(3):928-33.
  164. Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, Maris JM, Diller L, Look AT, George RE. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study. Clin Cancer Res. 2006 Oct 1; 12(19):5693-7.
  165. Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, Diller LR, Constine LS, Smith RA, Mahoney MC, Morris EA, Montgomery LL, Landier W, Smith SM, Robison LL, Oeffinger KC. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 2010 Apr 6; 152(7):444-55; W144-54.
  166. Brown SD, Vansonnenberg E, Morrison PR, Diller L, Shamberger RC. CT-guided radiofrequency ablation of pediatric Wilms tumor in a solitary kidney. Pediatr Radiol. 2005 Sep; 35(9):923-8.
  167. Dubois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF, Cohn SL, Pearson A, Diller L. Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2008 Nov; 51(5):589-92.
  168. George RE, Sanda T, Hanna M, Fröhling S, Luther W, Zhang J, Ahn Y, Zhou W, London WB, McGrady P, Xue L, Zozulya S, Gregor VE, Webb TR, Gray NS, Gilliland DG, Diller L, Greulich H, Morris SW, Meyerson M, Look AT. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature. 2008 Oct 16; 455(7215):975-8.
  169. Granger M, Grupp SA, Kletzel M, Kretschmar C, Naranjo A, London WB, Diller L. Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Nov; 59(5):902-7.
  170. Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009 Jan 28; 301(4):404-14.
  171. Casillas J, Syrjala KL, Ganz PA, Hammond E, Marcus AC, Moss KM, Crespi CM, Lu P, McCabe MS, Ford JS, Jacobs LA, Pucci D, Palmer SC, Termuhlen AM, Diller L, Campbell M, Jones B, Friedman DL. How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG™ Survivorship Center of Excellence Network. J Cancer Surviv. 2011 Dec; 5(4):371-81.
  172. Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 2013 Sep; 14(10):999-1008.
  173. Sarno JE, Rusk HA, Diller L, Sarno MT. The effect of hyperbaric oxygen on the mental and verbal ability of stroke patients. Stroke. 1972 Jan-Feb; 3(1):10-5.
  174. Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer. 2014 Apr 1; 120(7):1068-75.
  175. Yeh JM, Nohria A, Diller L. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med. 2014 May 20; 160(10):661-71.
  176. Tieu MT, Cigsar C, Ahmed S, Ng A, Diller L, Millar BA, Crystal P, Hodgson DC. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer. 2014 Aug 15; 120(16):2507-13.
  177. Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA. Neuroblastoma. Nat Rev Dis Primers. 2016 Nov 10; 2:16078.
To schedule an appointment: Call 617-632-5642

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close